Annals of Coloproctology, published by the Korean Society of Coloproctology, is a distinguished open access journal since 2011 that plays a pivotal role in the field of gastroenterology and surgery. With a strong focus on advancing knowledge and research in the areas of colorectal diseases, the journal provides a platform for researchers, clinicians, and healthcare professionals to share their findings and insights. The journal holds a commendable Q2 ranking in Surgery and Q3 in Gastroenterology as of 2023, underscoring its significance within the scientific community. Located in South Korea, it is committed to disseminating robust and innovative research that contributes to the enhancement of clinical practices and patient outcomes. The Annals of Coloproctology not only encourages the exchange of high-quality research articles but also ensures accessibility for a global audience, emphasizing the importance of collaborative efforts in tackling colorectal health challenges.

Intestinal Research is an influential open-access journal dedicated to advancing knowledge in the field of gastroenterology. Published by the Korean Association for the Study of Intestinal Diseases, this journal has been providing valuable insights into intestinal health since its inception in 2003. With an impressive impact factor and a current ranking of Q2 in the gastroenterology category, it is recognized among the top journals in its field, achieving a remarkable 82nd percentile in Scopus rankings. Based in South Korea, the journal's mission is to facilitate research and discussions on intestinal diseases, pathophysiology, innovative treatments, and advancements in care practices. By offering open access, Intestinal Research ensures that critical findings are readily available to researchers, healthcare professionals, and students alike, fostering global collaboration and sharing of knowledge. The journal accepts contributions that reflect the latest developments and foster deep understanding within the intestinal disease research community.

Gastrointestinal Disorders is a prominent open-access journal published by MDPI, based in Switzerland, that focuses on the latest research and innovations in the fields of gastroenterology, hepatology, and immunology. Since its inception in 2019, the journal has provided a vital platform for researchers and professionals to disseminate their findings, engaging with a global audience keen on advancing knowledge in gastrointestinal health. With a dedicated commitment to high-quality, peer-reviewed articles, Gastrointestinal Disorders has gained recognition in 2023, achieving Q3 status in gastroenterology and notable rankings in several other categories, including a respectable position in the quartiles for hepatology, immunology, and oncology. Despite its recent establishment, the journal has quickly become a valuable resource, facilitating open access to critical insights in the study of gastrointestinal diseases and their management, ensuring that emerging research is readily available to inform clinical practice and educate future professionals.

International Journal of Colorectal Disease is a prestigious peer-reviewed journal published by Springer that focuses on the evolving landscape of colorectal diseases. Established in 1986, this journal has served as a vital platform for researchers, healthcare professionals, and students to explore groundbreaking research, innovative treatment methodologies, and the latest advancements in gastroenterology. With an impressive impact factor and ranked in the Q2 category of gastroenterology by Scopus, it holds a prominent position in the academic community, currently occupying the 59th rank among 167 journals in the field, corresponding to the 64th percentile. Although it does not offer open access, the journal remains invaluable for those seeking in-depth analysis and comprehensive insights into colorectal health issues. As it continues through its convergence years until 2024, the International Journal of Colorectal Disease invites contributions that aim to bridge the gap between research and clinical practice, fostering a deeper understanding of colorectal disorders and enhancing patient care.

International Journal of Gastrointestinal Intervention is a distinguished open-access journal published by the SOC GASTROINTESTINAL INTERVENTION that has been committed to disseminating critical research since its inception in 2012. Based in the Netherlands, this journal focuses on the dynamic fields of gastroenterology, hepatology, oncology, and radiology, offering a platform for innovative studies and clinical interventions that can significantly impact patient care and medical practice. With its incorporation into Scopus and ranked within the lower quartiles in various categories as of 2023, the journal acknowledges the evolving landscape of medical research and seeks to continually elevate its contributions to knowledge in these specialized areas. By embracing open access since its founding, the journal ensures that cutting-edge research findings are accessible to a global audience, fostering collaboration and knowledge sharing among researchers, professionals, and students. The journal aims to be a premier source of information and a catalyst for advancements in gastrointestinal interventions, making it an essential resource for those dedicated to improving health outcomes in these critical medical fields.

Esophagus is a prestigious journal published by SPRINGER JAPAN KK, dedicated to advancing the field of gastroenterology. With an ISSN of 1612-9059 and E-ISSN 1612-9067, this journal has been a significant resource for researchers and practitioners since its inception in 2003. Covering a comprehensive range of topics related to esophageal health, diseases, and treatment advancements, Esophagus has established itself in the academic community, boasting a notable impact factor and achieving a ranking of #60 out of 167 in the gastroenterology category, placing it in the 64th percentile. The journal currently holds a Q2 status for the year 2023, emphasizing its contribution to high-quality research in the field. Located in the heart of Tokyo, Japan, this journal aims to foster collaboration and innovation within the gastroenterological community, welcoming submission of original research articles, review papers, and case studies that can significantly impact patient care and clinical practices.

Urology Research and Practice, published by AVES in Turkey, is an essential open-access journal dedicated to advancing the field of urology. With its inaugural issues released in 2023, the journal aims to disseminate cutting-edge research, innovative practices, and insightful clinical studies pertinent to urology, thereby fostering knowledge and collaboration among researchers, healthcare professionals, and students alike. Currently indexed in Scopus, it ranks Q3 in the urology category, reflecting its growing impact evidenced by a 47th percentile ranking in the Medicine Urology field. The journal not only serves as a platform for exceptional scholarly work but also emphasizes accessibility and inclusivity in scientific communication, allowing for a broader dissemination of urological knowledge globally. Explore groundbreaking research and contribute to the evolving landscape of urology through Urology Research and Practice.

Hepatobiliary & Pancreatic Diseases International, an esteemed journal published by Elsevier, stands as a vital resource within the field of gastroenterology and hepatology. Established in 2002, this journal has developed a significant reputation, currently ranked in the second quartile (Q2) in both categories as of 2023, showcasing its commitment to high-quality research and clinical studies. Based in Singapore, Hepatobiliary & Pancreatic Diseases International serves as an essential platform for researchers, clinicians, and healthcare professionals to share innovative findings, therapeutic approaches, and advancements in the understanding of hepatobiliary and pancreatic diseases. Although the journal does not currently offer Open Access, its rigorous peer-review process ensures that published articles maintain the highest scientific standards, fostering knowledge dissemination among the global research community. With a convergence period extending to 2024, this journal continues to play a pivotal role in enhancing the understanding and treatment of complex gastrointestinal conditions, making it a must-read for anyone engaged in this dynamic field.

Welcome to the Journal of Thoracic Disease, a premier scholarly journal dedicated to advancing the field of pulmonary and respiratory medicine. Published by AME PUBLISHING COMPANY in Hong Kong, this journal has established itself as a critical platform for the dissemination of innovative research and clinical advancements since its inception in 2009. With an impressive Q2 ranking in the Scopus category of Pulmonary and Respiratory Medicine, it is recognized for its contribution to the academic community, featuring a broad range of original research, reviews, and case studies that address contemporary challenges in thoracic disease management. The journal is committed to Open Access principles, ensuring that high-quality research is readily available to a global audience, further enhancing its impact factor and reach. Researchers, healthcare professionals, and students alike will find invaluable insights within its pages, making Journal of Thoracic Disease an essential resource for those invested in the respiratory health domain.

Urogynecology, published by Lippincott Williams & Wilkins, is a distinguished journal that serves as an essential platform for researchers, clinicians, and students in the fields of obstetrics, gynecology, surgery, and urology. With an impact factor that places it in the Q2 category in various specialties, the journal emphasizes high-quality, peer-reviewed research that contributes to advancements in women's health and pelvic floor disorders. As an Open Access journal, it is committed to enhancing the accessibility of its content, allowing for broader dissemination of knowledge and fostering collaborative efforts in the medical community. Located in India and addressing a global audience, Urogynecology has quickly established its reputation since its inception in 2022, continuing through its converged years until 2024. It is ranked favorably in Scopus across several medical categories, providing a vital resource for cutting-edge research and clinical practice insights. This journal aims to bridge gaps in knowledge and practice, making it an invaluable asset for anyone dedicated to improving outcomes in urogynecology.